Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1/2 Study to Evaluate Safety and Immunogenicity of a Prophylactic Plasmid DNA Booster Vaccine Against SARS-CoV-2 [Covigenix VAX-002] in Generally Healthy Adults 18 Years and Older

Next Previous
X
Search
Trial Profile

Phase 1/2 Study to Evaluate Safety and Immunogenicity of a Prophylactic Plasmid DNA Booster Vaccine Against SARS-CoV-2 [Covigenix VAX-002] in Generally Healthy Adults 18 Years and Older

Status: Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 23 Sep 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Covigenix VAX 002 (Primary)
  • Indications COVID 2019 infections
  • Focus Adverse reactions
  • Acronyms VAX-002-01
  • Sponsors Aegis Life; Entos Pharmaceuticals

    • Most Recent Events

    • 19 Sep 2024 According to an Aegis Life media release, the Phase 1 portion of this Phase 1/2 clinical trial has completed enrollment. The trial is being conducted at 12 sites in Canada.
    • 28 Aug 2024 Planned initiation date (estimated date of first participant enrollement) changed from 1 Jul 2024 to 1 Aug 2024.
    • 06 Aug 2024 According to Entos Pharmaceuticals media release,the trial is being conducted at 12 sites in Canada including sites planned in Alberta, Ontario, Quebec, and Nova Scotia. Jean-Francois Roussy is principal investigator at DIEX Recherche.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top